CAESAREA, Israel, Aug. 15, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Association of Diabetes Educators (AADE) annual conference at booth #348 on August 17-20, 2018 in Baltimore, Maryland. In addition to providing product demos at the booth, a DarioEngage product exhibit will take place at 12:15 pm on Sunday, August 18 at the Exhibit Hall.

The AADE is a professional membership organization dedicated to improving diabetes care through innovative education, management, and support with more than 14,000 members including nurses, dietitians, pharmacists, and exercise specialists. DarioEngage will be introduced to approximately 3,000 diabetes educators who are expected to attend the AADE 2018 conference.

"Diabetes educators and coaches are key influencers in the adoption of digital health solutions to better manage diabetes. While DarioEngage has recently been implemented and used in the U.S. and around the world, we are very excited to launch and demonstrate the product that can be used on a broad, national scale at the premier U.S. conference for diabetes coaches," commented Erez Raphael, Chairman and CEO of DarioHealth. "We see diabetes coaches as our partners in improving diabetes management and we are committed to supporting them with the best in digital health solutions to help them improve patient outcomes."

DarioEngage is a next generation digital platform for personalized diabetes coaching. The digital health solution provides a closed loop for diabetes management by connecting care providers to their patients' blood glucose data and behavioral information, accurately and in real time. The scalable DarioEngage platform saves diabetes coaches time and makes communications with their patients simple and highly effective through the use of real time data and alerts, predictive algorithms, and digital communications.

About DarioHealth Corp.

DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company serving its users with dynamic mobile health solutions. In today's day and age, knowledge of health and treatment is being democratized, and we believe people deserve to know everything about their own health and have the best tools to manage their condition. DarioHealth employs a revolutionary approach whereby harnessing big data, we have developed a novel method for chronic disease data management, empowering people to analyze and personalize self-diabetes management in a totally new way without having the disease slow them down. DarioHealth has a commercial office in New York with an R&D center in Caesarea, Israel. For more information, visit http://mydario.investorroom.com/.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" are intended to identify forward-looking statements. For example, when the Company describes that DarioEngage can be used on a broad, national scale, it is using forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact:
Joao Mendes-Roter
VP Marketing
joao@mydario.com
+1-914-775-5548

DarioHealth Investor Relations Contact:
Westwicke Partners
Dario@Westwicke.com
+1-443-213-0500

SOURCE DarioHealth Corp.